LGALS9 and dermatomyositis: Additionally, serum Gal-9 levels in patients with DM were more than 3-fold higher than in patients with IMNM [23.7 (12.3–35.9) vs. 7.4 (5.2–10.8) ng/mL, p < 0.001] (Figure 1A).